Servier
| Candidate | Targets | Indication | Partner | Our Commercial Rights | Discovery | Preclinical | IND- enabling | Phase I | Phase Ib/IIa |
|---|---|---|---|---|---|---|---|---|---|
|
Servier 3 Programs |
n.d./n.d. Bispecific |
Immuno-Oncology |  | U.S. for 1 bispecific |
Discovery Phase in progress
|
Pre-Clinical Phase not started
|
IND-enabling Phase not started
|
Phase 1 not started
|
Phase 2 not started
|